Search clinical trials for: Apixaban placebo

Total 53847 results

Portola Pharmaceuticals

Completed

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 1 of 4)

Healthy Volunteers

United States
Pfizer
Bristol-Myers Squibb

Completed

Bioavailability Study Comparing Modified Release To Immediate Release Apixaban Tablets In Healthy Volunteers

Thrombosis

United States
Janssen Research & Development, LLC
Bristol-Myers Squibb

Recruiting

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (LIBREXIA-AF)

Atrial Fibrillation

Belgium, United States, Italy, Japan, Taiwan, South Africa, Korea, Republic of, Poland, Chile, Serbia, Israel, France, Netherlands, Denmark, Hungary, Argentina, Australia, China, Spain, New Zealand, Czechia, Bulgaria, Croatia, Malaysia, German... and more
Hyogo College of Medicine

Completed

Impact of Apixaban on Clinical Outcome of the Patients With Large Vessel Occlusion or Stenosis Trial (ALVO)

Ischemic Stroke

Japan
Bayer

Completed

Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications. (PACIFIC-AF)

Atrial Fibrillation (AF)

Spain, Belgium, Latvia, Italy, Switzerland, Canada, Austria, Japan, Czechia, Hungary, Netherlands, Sweden, France, United Kingdom
Bristol-Myers Squibb
Pfizer

Completed

Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism

Venous Thrombosis

Argentina, Australia, Canada, China, Czech Republic, India, Italy, Korea, Republic of, United States, Spain, France, Brazil, Russian Federation, Mexico, Austria, Denmark, Germany, Hungary, Israel, Portugal, Romania, Singapore, Norway, Chil... and more
Bayer

Terminated

A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke (OCEANIC-AF)

Atrial Fibrillation | Prevention of Stroke or Systemic Embolism

Canada, United States, Israel, Korea, Republic of, China, Taiwan, Belgium, Australia, Singapore, Malaysia, Slovakia, United Kingdom, Czechia, Latvia, Japan, Brazil, Lithuania, Germany, France, Sweden, Turkey, Switzerland, Estonia, Bul... and more
Korea University Guro Hospital
Dt&Sanomedics

Not yet recruiting

Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF Trial

Heart Failure | Cerebrovascular Disease | Sinus Rhythm

Korea, Republic of
Brazilian Clinical Research Institute
Hospital Israelita Albert Einstein; Hospital Moinhos de Vento; Hospital do Coracao and other collaborators

Terminated

Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19 (APOLLO)

Covid19 | Thrombosis

Brazil
Thomas L. Ortel
National Heart, Lung, and Blood Institute (NHLBI)

Completed

COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis

Covid19

United States
Bristol-Myers Squibb

Completed

Bioavailability of Apixaban Sprinkle Compared to Apixaban Capsules

Healthy Volunteers

United States
Bristol-Myers Squibb

Completed

Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery

Deep Vein Thrombosis | Pulmonary Embolism

United States, Argentina, Brazil, Mexico, Russian Federation, Australia, Canada, Hungary, Israel, Turkey, Denmark, Poland, Sweden
Assistance Publique - Hôpitaux de Paris
Bristol-Myers Squibb

Active, not recruiting

API-CAT STUDY for APIxaban Cancer Associated Thrombosis (API-CAT)

Cancer-associated Thrombosis

France, Spain, Netherlands, Belgium, Austria, Greece, Switzerland, Canada, Italy, Poland, United Kingdom
The Affiliated Hospital of Qingdao University

Completed

Bioequivalence Study of Apixaban Tablets in Healthy Chinese Subjects

Healthy

China
McMaster University

Recruiting

Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease (EXPAND)

Crohn Disease | Ulcerative Colitis | Venous Thromboembolism | Colorectal Disorders | Pulmonary Embolism | IBD

Canada
Brigham and Women's Hospital

Active, not recruiting

Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism (HI-PRO)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
Baim Institute for Clinical Research
Bristol-Myers Squibb

Completed

Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation (AEIOU)

Atrial Fibrillation

United States
Doasense GmbH

Active, not recruiting

Pharmacokinetics and Point of Care Testing of Direct Oral Anticoagulants Subjects (PHAPOCU)

Anticoagulant Therapy

Germany
University Hospital, Geneva
Sunnybrook Health Sciences Centre

Not yet recruiting

The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis (API-CALF)

Deep Vein Thrombosis
Bristol-Myers Squibb

Completed

BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery

Venous Thrombosis | Pulmonary Embolism

United States, Argentina, Canada, Mexico, Puerto Rico, Israel, Australia, Poland, Denmark
Bristol-Myers Squibb

Completed

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery (ADVANCE-2)

Deep Vein Thrombosis | Pulmonary Embolism

Italy, Korea, Republic of, China, Spain, South Africa, Colombia, Austria, France, Germany, Israel, Russian Federation, Denmark, Belgium, Singapore, Brazil, Mexico, Norway, Philippines, Poland, Ukraine, India, Malaysia, Hungary, Chile, Czech... and more
Bristol-Myers Squibb

Completed

Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)

Deep Vein Thrombosis | Pulmonary Embolism

Australia, Mexico, United Kingdom, United States, China, Spain, Denmark, France, Hungary, Israel, Russian Federation, Canada, Belgium, Argentina, Norway, Poland, Ukraine, India, Germany, Romania, Sweden
Universitaire Ziekenhuizen KU Leuven

Recruiting

Pharmacokinetics of Apixaban in Patients With Short Bowel Syndrome Requiring Long Term Parenteral Nutrition (ABSORB)

Anticoagulation | Short Bowel Syndrome

Belgium
Artivion Inc.
Duke Clinical Research Institute

Terminated

PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban

Aortic Valve Stenosis | Aortic Valve Disease | Aortic Valve Failure

United States
University Hospital, Caen
University Hospital, Rouen

Completed

Apixaban in Subjects With Peritoneal Dialysis (ApiDP)

Peritoneal Dialysis | Chronic Renal Insufficiency

France
Jewish General Hospital

Completed

Apixaban in Hemodialysis

End-stage Renal Disease

Canada
Pfizer
Bristol-Myers Squibb

Active, not recruiting

Treatment Patterns Among Patients With Venous Thromboembolism in the United States

Venous Thromboembolism

United States
Instituto de Investigacion Sanitaria La Fe
Bristol-Myers Squibb

Terminated

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Venous Thromboembolism

Spain
Meshalkin Research Institute of Pathology of Circulation

Unknown

Sidlenafil in Combination With Oral Anticoagulants in Patients With Intermediate-high Risk of Pulmonary Embolism (PSCAT)

Pulmonary Embolism | Intermediate-high Risk | Combination of Oral Anticoagulation Therapy and Sildenafil

Russian Federation
Universidade do Vale do Sapucai
Pfizer; Apsen Farmaceutica S.A.; Biofarma; Dermadia; Methodos Laboratory

Completed

Prevention of Complications (SARS-CoV-2): Clinical Study

Complication

Brazil
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery (TEXT-TKR)

VTE Prophylaxis With Anticoagulation After Total Knee Replacement Surgery

Belgium, Italy, Malaysia, Latvia, Spain, Turkey, Bulgaria, United States, Lithuania, Russian Federation, Ukraine, Japan, Argentina, Brazil, Canada, Poland
International Bio service

Not yet recruiting

Bioequivalence Study of Apixaban 5 mg Film-coated Tablets in Healthy Thai Volunteers

Healthy Volunteer
University of North Carolina, Chapel Hill
North Carolina Translational and Clinical Sciences Institute

Completed

Pharmacokinetics of Apixaban in Nephrotic Syndrome

Proteinuria | Nephrotic Syndrome

United States
Universitaire Ziekenhuizen KU Leuven
Bristol-Myers Squibb

Completed

Apixaban in End-stage Kidney Disease : A Pharmacokinetics Study

ESRD | Anticoagulant Toxicity

Belgium
University of North Carolina, Chapel Hill
American College of Clinical Pharmacy

Completed

A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome

Nephrotic Syndrome | Membranous Nephropathy

United States
Second Affiliated Hospital, School of Medicine,...

Unknown

A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent Venous Thromboembolism (VTE)

Venous Thromboembolism | Anticoagulants and Bleeding Disorders | Foot Ankle Injuries

China
Shanghai Zhongshan Hospital

Recruiting

A Multi-center Study of Apixaban(APPROACH)

Evaluate the Safety and Efficacy of Apixaban

China
Yonsei University

Recruiting

The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)

Atrial Fibrillation Patients With Intermediate Stroke Risk

Korea, Republic of
Frank C Sciurba
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80

COVID-19

United States
McMaster University

Completed

Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery

Surgery | Venous Thromboembolism | Adherence, Medication | Prophylaxis | Neoplasms Malignant

Canada
Hamilton Health Sciences Corporation
Population Health Research Institute

Unknown

Apixaban Dose Reduction in Patients With Elevated Drug Levels (ADREL)

Atrial Fibrillation

Canada
Sohag University

Not yet recruiting

"ORBIT" Versus "HAS-BLED" Scores in Predicting Major Bleeding in Patients With Atrial Fibrillation Receiving Oral Anticoagulants.

Patients With Atrial Fibrillation Receiving Oral Anticoagulants
Yonsei University

Recruiting

AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)

Atrial Fibrillation Patients With Moderate or High Stroke Risk Who Had Undergone Catheter Ablation of Atrial Fibrillation

Korea, Republic of
Hopital Lariboisière

Unknown

Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban (ECAN)

Coagulation Disorder | Non Valvular Atrial Fibrillation

France
Tinea Pharmaceuticals

Completed

Multicenter Study of the Efficacy and Safety of Luliconazole Cream in Tinea Pedis (Athlete's Foot)

Tinea Pedis

United States
University of Roma La Sapienza

Recruiting

Anticoagulation on Demand After Percutaneous Coronary Intervention in High Bleeding Risk Patients (INTERMITTENT)

Atrial Fibrillation | Ischemic Heart Disease

Italy
Humanis Saglık Anonim Sirketi

Completed

Bioequivalence Study of Two Products of Apixaban 5mg Tablets in Healthy, Adult, Human Subjects

Antithrombic Drug

India
Intermountain Health Care, Inc.

Terminated

Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis (ARM-DVT)

Deep Vein Thrombosis | Venous Thromboembolism | Deep Venous Thrombosis | Thrombus | Upper Extremity Deep Venous Thrombosis

United States
Hospital Universitari de Bellvitge
Baxter Healthcare Corporation; Spanish Society of Nephrology

Completed

Study of Apixaban in Patients Receiving Hemodiafiltration (HEMOCIONA)

Atrial Fibrillation | Hemodialysis Complication

Spain
National Taiwan University Hospital Hsin-Chu Branch

Unknown

Apixaban for Prevention of Post-angioplasty Thrombosis of Hemodialysis Vascular Access

Hemodialysis Access Failure

Taiwan

Search clinical trials for: Apixaban placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations